Details of the Drug
General Information of Drug (ID: DMYSJRN)
| Drug Name |
Bromopride
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Bromopride hydrochloride; UNII-B7C7WX94Z6; B7C7WX94Z6; 52423-56-0; 4-amino-5-bromo-N-(2-diethylaminoethyl)-2-methoxybenzamide hydrochloride; Cascapride; Opridan; Bromopride HCl; Bromoprid hydrochlorid; EINECS 257-906-6; AC1MI3LY; SCHEMBL8385045; CTK8J0119; AKOS027380919; KB-289931; 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxybenzamide monohydrochloride
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| ATC Code | |||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

